DXR Share Price

Open 7.03 Change Price %
High 7.04 1 Day 0.00 0.00
Low 7.02 1 Week 0.00 0.00
Close 7.03 1 Month 0.22 3.23
Volume 111 1 Year -0.85 -10.79
52 Week High 9.80
52 Week Low 0.00
DXR Important Levels
Resistance 2 7.05
Resistance 1 7.04
Pivot 7.03
Support 1 7.02
Support 2 7.01
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
GST 0.94 11.90%
UEC 1.62 15.71%
ROX 1.83 7.65%
ROX 1.83 7.65%
SYN 0.64 -9.86%
SYN 0.64 -9.86%
RBY 0.03 -70.00%
More..
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
More..
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
CPHI 0.22 -21.43%
SNT 0.12 -20.00%
INV 0.14 -17.65%
More..

Daxor Corporation (AMEX: DXR)

DXR Technical Analysis 5
As on 8th Jun 2017 DXR Share Price closed @ 7.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 7.98 & Strong Sell for SHORT-TERM with Stoploss of 7.39 we also expect STOCK to react on Following IMPORTANT LEVELS.
DXR Target for June
1st Target up-side 11.14
2nd Target up-side 14.19
3rd Target up-side 17.23
1st Target down-side 2.46
2nd Target down-side -0.59
3rd Target down-side -3.63
DXR Other Details
Segment EQ
Market Capital 33775400.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.daxor.com
DXR Address
DXR
Empire State Building
350 Fifth Avenue
New York, NY 10118
United States
Phone: 212-244-0555
Fax: 212-244-0806
DXR Latest News
Daxor Corp (NYSEMKT:DXR) Institutional Investor Sentiment Analysis   Weekly Register   - 21st Jun 17
Daxor Corporation (DXR)'s Stock Is Sell After Forming   WeeklyHub   - 19th Jun 17
Daxor Corp (NYSEMKT:DXR) 2016 Q4 Sentiment Report   Weekly Register   - 01st Jun 17
Daxor Corporation Announces Hiring of Chief Financial Officer   Marketwired (press release)   - 31st May 17
Form 8-K DAXOR CORP For: May 16   StreetInsider.com   - 16th May 17
Daxor Corporation Announces Death of Founder, Chief Medical Officer, and ...   Marketwired (press release)   - 02nd Feb 17
Daxor Corp. (DXR) Names New CFO   StreetInsider.com   - 17th Jun 16
Daxor Corporation Announces Filing of Form N-CSR for December 31, 2014   Marketwired (press release)   - 27th Feb 15
BRIEF-Daxor Corp hires John Wilkens as CFO effective immediately   Reuters   - 21st Aug 14
DXR US: NYSE MKT   MarketWatch   - 10th Oct 10
Interactive Technical Analysis Chart Daxor Corporation ( DXR AMEX USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Daxor Corporation
DXR Business Profile
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.